IGF-1 DES vs hGHRH(1-37)OH

Head-to-head comparison of IGF-1 DES (Des(1-3) Insulin-like Growth Factor 1) and hGHRH(1-37)OH (Human growth hormone-releasing factor (1-37) hydroxyl) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyIGF-1 DEShGHRH(1-37)OH
CategoryGrowth HormoneGrowth Hormone
Full NameDes(1-3) Insulin-like Growth Factor 1Human growth hormone-releasing factor (1-37) hydroxyl
Molecular Weight7365 DaN/A
Half-Life~20-30 minutes5-20 minutes
Amino Acids6737
Typical Dose1-2 mcg/kg
RouteSubcutaneous/IV
Purity>98%≥98%
Studies Count6560
Research StatusActive ResearchClinical Research

IGF-1 DES Benefits

  • Highly potent localized muscle growth, enhanced protein synthesis, satellite cell proliferation, does not bind to IGFBPs, rapid onset

hGHRH(1-37)OH Benefits

  • GH release studies
  • minimal-sequence mapping
  • receptor pharmacology
  • peptide stability research

IGF-1 DES Dosing

50-150 mcg per injection site bilaterally post-workout. 4-6 week cycles due to potency. Multiple daily injections in research.

hGHRH(1-37)OH Dosing

1-2 mcg/kg SC or IV bolus|acute stimulation with serial GH assays|short-course research administration with biomarker monitoring

IGF-1 DES Side Effects

  • Hypoglycemia (dose-dependent), localized swelling, shorter duration limits systemic exposure compared to IGF-1 LR3.

hGHRH(1-37)OH Side Effects

  • flushing
  • headache
  • transient fatigue

Research Overview

IGF-1 DES

Missing first three amino acids (Gly-Pro-Glu) eliminates IGFBP binding, resulting in 100% bioavailable IGF-1R stimulation. Activates PI3K/Akt/mTOR for protein synthesis and satellite cell proliferation.

hGHRH(1-37)OH

Human GHRF(1-37)OH has appeared in studies examining how loss of C-terminal residues affects biological activity at the GHRH receptor. It is often used alongside other fragments to define structure-activity relationships within the GHRH family.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

IGF-1 DES stacks with:

PEG-MGFIGF-1 LR3CJC-1295

hGHRH(1-37)OH stacks with:

L-arginineL-lysineglycine
growth-factorIGF-1-analogmuscle-growthanaboliclocalized-growthghrhfragmentstructure-activityendocrinology